Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02144584 · ClinicalTrials.gov registry record · Early Phase 1
Memantine for Enhanced Stroke Recovery
A Early Phase 1 study of Ischemic Stroke and Upper Extremity Weakness, sponsored by University of Utah.
- Active
- Registry status
- Early Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT02144584: Active Early Phase 1 study of Ischemic Stroke and Upper Extremity Weakness, sponsored by University of Utah.
NCT02144584 is a Early Phase 1 study of Ischemic Stroke and Upper Extremity Weakness that is active but no longer recruiting, run by University of Utah. The registered enrollment target is 20 participants, below the 1,463-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02144584, a Early Phase 1 study of Ischemic Stroke and Upper Extremity Weakness, is active but no longer recruiting, sponsored by University of Utah.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This will be a randomized double blind placebo-controlled pilot study using a repeated measures design in which participants with acute ischemic stroke and upper extremity weakness are randomized to either drug or placebo
Primary Outcome
Fugl-Meyer Assessment UE and LE scales (FMUE and FMLE). Our primary outcome measures will be the scores on the FMUE and FMLE as they have been shown to have good reliability and validity. These scales measure motor impairment by asking the participant to perform various arm, hand, and leg motions. Items are scored on a 3-point scale with 0 representing no movement, 1 representing the inability to complete the entire item and 2 representing ability to complete the item as asked. Scores range fro
Conditions Studied
Interventions
- DRUG Memantine XR
- DRUG Placebo (for memantine)
Study Locations (1)
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2014-01 |
| Est. Completion | 2026-12 |
| Phase | Early Phase 1 |
What the registry record for NCT02144584 still lists
NCT02144584 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,463-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Ischemic Stroke appearing as the primary indexed condition, and to 2 interventions - of which Memantine XR is the first listed.
NCT02144584 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT02144584 about?
NCT02144584 is a clinical study titled "Memantine for Enhanced Stroke Recovery". This will be a randomized double blind placebo-controlled pilot study using a repeated measures design in which participants with acute ischemic stroke and upper extremity weakness are randomized to either drug or placebo
What is the current status of trial NCT02144584?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 20 participants. The study started on 2014-01. Estimated completion is 2026-12.
What conditions does trial NCT02144584 study?
This clinical trial studies the following conditions: Ischemic Stroke, Upper Extremity Weakness.
What interventions are being tested in trial NCT02144584?
The interventions under investigation include: Memantine XR (DRUG), Placebo (for memantine) (DRUG).
Who is sponsoring clinical trial NCT02144584?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02144584 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ischemic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02144584's enrollment target sits among peer trials
20 55th of 66 higher than 9 of 66 other Ischemic Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ischemic Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hyperbaric Oxygen and Manipulative Therapies to Regain Function Post Stroke
COMPLETED · Early Phase 1
-
A Study Of Vagus Nerve Stimulation (VNS) With Mobility Training For Gait Recovery After Chronic Ischemic Stroke
RECRUITING · NA
-
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RECRUITING
-
Transitions of Care for Stroke Patients
RECRUITING
-
Personalized Transcranial Direct Current Stimulation in Stroke Recovery
RECRUITING · NA
-
Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia